Skip to main content
lexblog.com/lib/VZSM1YQ7viewrecordjson
LEX-WK-VZSM1YQ7crawled 2021-11-09 09:42Z

Litigation Spotlight Update: The Infliximab (Remicade®) Litigation

Daniel R. McCallum · Biosimilars Law Bulletin · Published February 5, 2018

Work details

firm or organization
Rothwell Figg
published
2018-02-05

Citation

Daniel R. McCallum, Litigation Spotlight Update: The Infliximab (Remicade®) Litigation, Biosimilars Law Bulletin (February 5, 2018) [The Library at LexBlog, LEX-WK-VZSM1YQ7, lexpid.org/VZSM1YQ7]